Advisory Committees

March 20, 2014: Vaccines and Related Biological Products Advisory Committee Meeting Draft Agenda

Food and Drug Administration
Center for Biologics Evaluation and Research
Vaccines and Related Biological Products Advisory Committee
136th Meeting via Teleconference
Rockwall II, Conference Room 1033
5515 Security Lane, Rockville, MD
March 20, 2014

March 20, 2014: DRAFT AGENDA
Open Session
11:30 a.m.Call to Order and Opening RemarksRobert Daum, M.D., Chair
Conflicts of Interest StatementPrabha Atreya, Ph.D., DFO
Presentation of Laboratory of Respiratory and Special Pathogens, Division of Bacterial, Parasitic and Allergenic Products and Laboratory of Hepatitis Viruses, Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research
11:40 a.m.Overview of Research/Site Visit Process,
Center Biologics Evaluation and Research (CBER)
Carolyn Wilson, Ph.D., FDA
12:10 p.m.Overview Division of Bacterial, Parasitic and Allergenic Products, OVRRJay Slater, M.D., FDA
12:25 p.m.Overview Laboratory of Respiratory and Special  PathogensMichael Schmitt, Ph.D., FDA
12:40 p.m.Overview Division of Viral ProductsJerry Weir, Ph.D., FDA
12:55 p.m.Overview Laboratory of Hepatitis Viruses Marian Major, Ph.D., FDA
1:10 p.m.Open Public Hearing (if no speakers, will move directly to closed session)
2:10 p.m.Closed Session
3:20 p.m.Adjourn Meeting

Page Last Updated: 08/24/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English